ProtoKinetix, Incorporated
OTC: PKTX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Michael Richard Guzzetta
- Employees
- 5
- Headquarters
- Marietta, United States
- IPO year
- 2002
- Market cap
- $2.0M
- Website
- https://www.protokinetix.com
Loading PKTX…
Loading profile data…Frequently asked questions about PKTX
What does ProtoKinetix, Incorporated (PKTX) do?
ProtoKinetix, Incorporated is a biotechnology firm engaged in research and development, specializing in the scientific and medical investigation of glycoproteins known as anti-freeze glycoproteins (AFGPs) and anti-aging glycoproteins (AAGPs). These AFGPs are particularly relevant for their commercial potential within the healthcare sector, with...
Where does PKTX trade?
ProtoKinetix, Incorporated (PKTX) trades on the Other OTC.
What sector is PKTX in?
ProtoKinetix, Incorporated (PKTX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of ProtoKinetix, Incorporated?
Michael Richard Guzzetta is the chief executive officer of ProtoKinetix, Incorporated (PKTX).
Where is ProtoKinetix, Incorporated headquartered?
ProtoKinetix, Incorporated is headquartered in United States.
Does PKTX pay a dividend?
ProtoKinetix, Incorporated (PKTX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PKTX go public?
ProtoKinetix, Incorporated (PKTX) completed its initial public offering in 2002.